Arno Therapeutics
30 Two Bridges Road
Suite 270
Fairfield
New Jersey
07004
United States
Tel: 862-703-7170
Fax: 973-227-5759
Website: http://www.arnothera.com/
Email: info@arnothera.com
99 articles about Arno Therapeutics
-
Arno Therapeutics Announces Cooperative Research And Development Agreement With US Army Medical Research Institute Of Infectious Diseases To Test Antiviral Activity Of AR-12
6/3/2015
-
Arno Therapeutics Announces AR-12 Antiviral Data Against Multiple Hemorrhagic Fevers Published Online In Antiviral Research
5/29/2015
-
Arno Therapeutics Reports First Quarter 2015 Financial And Business Update
5/18/2015
-
Arno Therapeutics Announces Preclinical Data Demonstrating Broad-Spectrum Antiviral Activity For AR-12
5/15/2015
-
Arno Therapeutics Announces Data Validating Continued Onapristone And Companion Diagnostic Development At ASCO Annual Meeting 2015
5/14/2015
-
Arno Therapeutics Receives USPTO Notice Of Allowance For Two Important Patents Covering Lead Compound Onapristone
5/7/2015
-
Arno Therapeutics Receives European Orphan Drug Designation For AR-12 To Treat Two Infectious Diseases
4/30/2015
-
Arno Therapeutics To Present Promising Data From Phase I Trial Of Onapristone At AACR Annual Meeting 2015
4/21/2015
-
Arno Therapeutics Announces Three Poster Presentations At Upcoming American Association for Cancer Research Annual Meeting 2015
4/13/2015
-
Arno Therapeutics Reports Fourth Quarter 2014 Financial And Business Update
4/1/2015
-
New Data Supporting Arno Therapeutics' HDAC Inhibitor AR-42 Published In The Journal of Urology
3/24/2015
-
Arno Therapeutics To Present At 11th Annual Noble Equity Conference
1/8/2015
-
Arno Therapeutics Doses First Patient In Expansion Stage Of Modified Phase 1/2 Trial Evaluating Onapristone In Progesterone Receptor Positive Tumors
12/10/2014
-
Arno Therapeutics To Present Data Further Validating Diagnostic Development Of CDX For Onapristone At San Antonio Breast Cancer Symposium 2014
12/9/2014
-
Arno Therapeutics Appoints Alexander Zukiwski, M.D. To Board Of Directors
12/5/2014
-
Arno Therapeutics To Present At LD Micro Conference 2014
11/24/2014
-
Arno Therapeutics Reports Third Quarter 2014 Financial And Business Update
11/17/2014
-
Arno Therapeutics' Executive Selected To Present At 5th Annual Clinical Affairs And Regulatory Approvals For Diagnostics Conference
10/29/2014
-
Arno Therapeutics Advances Phase I Trial Evaluating Onapristone In Progesterone Receptor Positive Tumors To Expansion Stage
10/27/2014
-
Arno Therapeutics To Present Encouraging Data From Ongoing Phase 1/2 Trial Evaluating Onapristone In CRPC At 21st Annual PCF Scientific Retreat
10/23/2014